Why We're Doubling Down on MAKO Surgical

Before you go, we thought you'd like these...
Before you go close icon

The following video is part of our "Motley Fool Conversations" series, in which analyst John Reeves and advisor David Meier discuss topics across the investing world.

MAKO Surgical just got taken to the woodshed after its recent earnings release. It was brutal and painful and extremely unpleasant all the way around. And we're buying more shares for our real-money portfolio. David feels that the system and procedures numbers are all heading in the right direction, and there's still a ton of opportunity out there.

Motley Fool co-founder David Gardner is bullish on MAKO Surgical, and he believes it's poised for monster returns. To learn more about this top pick today, enjoy the special free report: "Discover the Next Rule-Breaking Multibagger."Don't miss out on this limited-time offer and your opportunity to discover this game-changing company before the market does. Click here to access your report -- it's totally free.

At the time this article was published David Meierhas no positions in the stocks mentioned above.John Reeveshas no positions in the stocks mentioned above. The Motley Fool owns shares of Intuitive Surgical, Johnson & Johnson, MAKO Surgical, and Zimmer Holdings.Motley Fool newsletter services recommendIntuitive Surgical, Johnson & Johnson, MAKO Surgical, and Stryker. Try any of our Foolish newsletter servicesfree for 30 days. We Fools may not all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. The Motley Fool has adisclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners